First Solar vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 24)

First Solar

EmergingClimate & Energy

General

Tempe AZ US solar module leader (NASDAQ: FSLR) at $4.2B 2024 revenue (+27%) with 23.5 GW total capacity; $330M South Carolina factory adding 3.7 GW and EPEAT Climate+ certified competing with Qcells for IRA-compliant domestic utility solar.

AI VisibilityBeta
Overall Score
D24
Category Rank
#877 of 1167
AI Consensus
55%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
16
Gemini
27

About

First Solar, Inc. is a Tempe, Arizona-based solar module manufacturer — publicly traded on NASDAQ (NASDAQ: FSLR) as an S&P 500 component — operating as the largest US solar manufacturer and the only vertically integrated thin-film cadmium telluride (CdTe) solar module company at commercial scale, with 23.5 GW of total nameplate manufacturing capacity across facilities in the United States (Ohio, Alabama, Louisiana), India, Vietnam, and Malaysia as of 2025. In fiscal year 2024, First Solar reported $4.2 billion in net sales (a 27% increase from $3.3 billion in 2023) with a record 14.1 GW of modules sold. In 2025, First Solar committed $330 million to a new South Carolina factory in Gaffney (3.7 GW capacity, ~600 jobs, operations H2 2026) that would bring total US capacity to 17.7 GW. First Solar's CdTe modules have achieved commercial production efficiencies exceeding 20%, and the company holds first-mover status with the EPEAT Climate+ designation for ultra-low carbon solar technology. CEO Mark Widmar leads the company. Founded 1990 in Perrysburg, Ohio.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

24
Overall Score
90
#877
Category Rank
#9
55
AI Consensus
60
stable
Trend
stable
35
ChatGPT
99
16
Perplexity
99
27
Gemini
83
27
Claude
96
19
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.